drugset / Trial / NCT04859465
Albumin-bound Paclitaxel Combined With Liposomal Doxorubicin in the Treatment of Advanced or Unresectable Angiosarcoma
NaSingle-groupOpen-labelTreatment
Summary
The purpose is to explore the efficacy and safety of the combination of albumin-bound paclitaxel and liposomal doxorubicin in the treatment of advanced or unresectable angiosarcoma.
Timeline
- Start
- 2021-05-21
- Primary completion
- 2027-05-20
- Completion
- 2027-11-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Doxorubicin | Other / unclassified | 35 mg/m2 | Intravenous |
| Subject | Paclitaxel | Small molecule | 220 mg/m2 | Intravenous |